期刊文献+

β-tubulin-Ⅲ、E-cadherin和α-catenin在乳腺癌及癌前病变中的表达及诊断意义 被引量:8

The expressions and diagnostic significance of β-tubulin-Ⅲ,E-cadherin and α-catenin in precancerous Lesions and carcinoma of the breast
原文传递
导出
摘要 目的探讨乳腺癌前病变及浸润性癌中β-tubulin-Ⅲ、E-cadherin和α-catenin的表达及诊断意义。方法采用免疫组织化学Ultra Sensitive TM S-P法检测20例乳腺非典型导管上皮增生(ADH)、60例乳腺导管原位癌(DCIS)和90例浸润性乳腺癌(IDC)中的β-tubulin-Ⅲ、E-cadherin和α-catenin的表达,以30例正常乳腺组织作对照。结果β-tubulin-Ⅲ微管蛋白的表达:(1)β-tubulin-Ⅲ微管蛋白在正常对照组、ADH、DCIS和IDC组中表达率为22.0%,55.0%,71.7%,84.4%,4组间差异有统计学意义(χ2=22.298,P<0.05),两两组间比较,导管原位癌组、浸润性导管癌组与非典型导管增生组、正常对照组比较均差异有统计学意义(χ2=39.525,22.474,6.551,P<0.05)。2.E-cadherin和α-catenin的表达:在正常对照组、ADH、DCIS和IDC组中,E-cadherin的表达率分别为100%、75.0%、68.3%和41.1%,α-catenin的表达率为100.0%、80.0%、73.3%和56.7%,在四组中E-cadherin和α-catenin的表达差异有统计学意义(χ2=18.65,10.97,P<0.05)。结论乳腺癌前病变中β-tubulin-Ⅲ过表达,可能是乳腺癌形成的早期事件;E-cadherin和α-catenin在乳腺细胞过度增殖、恶性转化的过程中起重要作用,可作为判断组织病变程度及侵袭能力强弱的因素,β-tubulin-Ⅲ微管蛋白及E-cadherin、α-catenin有可能成为诊断和评估乳腺癌变和治疗的指标。 Objective To explore the expression and diagnostic significance of β-tubulin-Ⅲproteins,E-cadherin and α-catenin in breast precancerous lesions,including atypical ductal hyperplasia( ADH),ductal carcinoma in situ( DCIS) and invasive ductal carcinomas( IDC). Methods The expressions of β-tubulin-Ⅲ,E-cadherin and α-catenin were investigated by immunhistochemical Ultra Sensitive TM S-P method of precancerous Lesions including 20 cases of ADH,60 cases of DCIS,and 90 cases of carcinoma of the breast. 30 cases of normal breast tissues were selected as a control group. Results( 1) Significant differences of the β-tubulin-Ⅲ proteins expression were found among the four groups of normal breast tissues( 20%),ADH( 55. 0%),DCIS( 71. 7%) and IDC( 84. 4%),( χ2= 22. 298,P < 0. 05),( P < 0. 05).( 2) The expressions of E-cadherin and α-catenin in observed and controll groups: The expressions of E-cadherin in normal group,ADH,DCIS and IDC were 100%,75. 0%,68. 3% and 41. 1%. The expressions of α-catenin in normal group,ADH,DCIS and IDC groups were 100%,80. 0%,73. 3% and 56. 7%. There were significant differences of the expressions of E-cadherin and α-catenin between DCIS and IDC( χ2=18. 650,10. 970,P < 0. 05). Conclusions Abnormal expression of β-tubulin-Ⅲ may be an early event in the development of breast tumor. The aberration of β-tubulin-Ⅲ may play a key role during oncogenesis and promote breast cellular transformation into malignancy. The abnormal expressions of E-cadherin andα-catenin with the degree of breast disease relates to the development,progression and metastasis of breast carcinoma,which may serve as one of the parameters for diagnosis of breast carcinoma and determine biological behavior and prognosis of breast carcinoma.
出处 《中华诊断学电子杂志》 2013年第1期-,共4页 Chinese Journal of Diagnostics(Electronic Edition)
基金 日照市应用技术研究与开发计划项目(2060402-4) 济宁医学院2013年度科研计划重点项目(JY2013KJ051)
关键词 乳腺肿瘤 癌前病变 微管蛋白 钙黏素 连环蛋白 Breast neoplasms Precancerous Lesions Microtubulin Cadherin Catenin
  • 相关文献

参考文献3

二级参考文献38

  • 1刘敏,翟晓辉,王莹,金木兰,郭晓娟,李杰.乳腺肿瘤缺氧诱导因子-1α的表达与BOLD-MRI成像的关系研究[J].中华临床医师杂志(电子版),2012,6(20):65-68. 被引量:4
  • 2Bhattacharya R, Cabral F. A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell 2004; 15: 3123-3131.
  • 3Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res 2006; 12: 11-19.
  • 4Alli E, Bash-Babula J, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002; 62: 6864-6869.
  • 5Sève P, Mackey J, Isaac S, Trédan O, Souquet PJ, Pérol M, Lai R, Voloch A, Dumontet C. Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. Mol Cancer Ther 2005; 4: 2001-2007.
  • 6Sève P, Isaac S, Trédan O, Souquet PJ, Pachéco Y, Pérol M, Lafanéchère L, Penet A, Peiller EL, Dumontet C. Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. Clin Cancer Res 2005; 11: 5481-5486.
  • 7Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA, Kuick R, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003; 2: 107-116.
  • 8Mori N, Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J Neurosci Res 2002; 70: 264-273.
  • 9Chen W, Ji J, Xu X, He S, Ru B. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int J Dev Neurosci 2003; 21: 209-216.
  • 10Campostrini N, Marimpietri D, Totolo A, Mancone C, Fimia GM, Ponzoni M, Righetti PG. Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. Proteomics 2006; 6: 4420-4431.

共引文献13

同被引文献84

  • 1杨志寅.现代医学科学发展中的缺憾与思考[J].中华诊断学电子杂志,2013,1(1). 被引量:100
  • 2潘祥林,王鸿利.诊断学的任务与发展方向[J].中华诊断学电子杂志,2013,1(1). 被引量:51
  • 3李铁灵,郭海峰,杜晓宏.右半结肠癌中p53,ki-67的表达及与分化程度及Ducks分期的关系[J].牡丹江医学院学报,2007,28(4):17-19. 被引量:4
  • 4翟俊山,李楠,王卉,王艳梅,石玉玲,沙立娜,王欣.环氧合酶-2在胃癌组织中的表达及与患者预后的关系[J].中华消化内镜杂志,2007,24(5):379-381. 被引量:5
  • 5YouldenDR,CrambSM,BaadePD.TheInternationalEpidemiologyofLungCancer:geographicaldistributionandseculartrends[J].JThoracOncol,2008,3(8):819-831.
  • 6ZhangJ,KuaiX,SongM,etal.microRNA-32inhibitstheproliferationandinvasionoftheSGC-7901gastriccancercelllineinvitro[J].OncolLett,2014,7(1):270-274.
  • 7FuY,WeiX,TangC,etal.CirculatingmicroRNA-101asapotentialbiomarkerforhepatitisB virus-relatedhepatocellularcarcinoma[J].OncolLett,2013,6(6):1811-1815.
  • 8ZhangX,LiX,TanZ,etal.MicroRNA-373isupregulatedandtargets TNFAIP1 in human gastric cancer,contributing totumorigenesis[J].OncolLett,2013,6(5):1427-1434.
  • 9KitamuraK,SeikeM,OkanoT,etal.MiR-134/487b/655clusterregulatesTGF-beta-inducedepithelial-mesenchymaltransitionanddrug resistance to gefitinib by targeting MAGI2 in lungadenocarcinomacells[J].MolCancerTher,2014,13(2):444-453.
  • 10ZhaoC,XuY,ZhangY,etal.DownregulationofmiR-145contributestolungadenocarcinomacellgrowthtoformbrainmetastases[J].OncolRep,2013,30(5):2027-2034.

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部